Review



γ-aminobutyric acid  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    TargetMol γ-aminobutyric acid
    γ Aminobutyric Acid, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/γ-aminobutyric acid/product/TargetMol
    Average 94 stars, based on 2 article reviews
    γ-aminobutyric acid - by Bioz Stars, 2026-03
    94/100 stars

    Images



    Similar Products

    97
    ATCC gamma aminobutyric acid gaba metabolite
    Gamma Aminobutyric Acid Gaba Metabolite, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gamma aminobutyric acid gaba metabolite/product/ATCC
    Average 97 stars, based on 1 article reviews
    gamma aminobutyric acid gaba metabolite - by Bioz Stars, 2026-03
    97/100 stars
      Buy from Supplier

    94
    Developmental Studies Hybridoma Bank mouse monoclonal antigabra5
    Mouse Monoclonal Antigabra5, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse monoclonal antigabra5/product/Developmental Studies Hybridoma Bank
    Average 94 stars, based on 1 article reviews
    mouse monoclonal antigabra5 - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    95
    Alomone Labs gamma aminobutyric acid receptor gabar blockers
    Isolated NMDARs show loss of function in mice with GluN1 Y647S +/− patient variant (A) Schematic showing the position of the Y647S mutation in the M3 transmembrane domain of the GluN1 NMDAR subunit (top), structure of the human GluN1-GluN2A NMDAR tetramer (PDB: 6IRF ) highlighting the Y647 site in the channel pore (bottom). (B) Tyrosine residue at the 647 th position of GluN1 is mutated to serine, causing severe seizures and intellectual disability in the patient. Mutant mice ( Grin1 Y647S +/− ) replicating the patient phenotype were used for slice electrophysiology. (C) Coronal prefrontal cortex slices from adult WT and mutant (Y647S +/− ) mice were used to record synaptic currents evoked by electrical stimulation of glutamate release in layer 5 pyramidal (L5 Pyr) neurons. (D) Schematic with position of stimulating and recording electrodes in the brain slice. Isolated AMPAR EPSCs measured using cesium gluconate patch pipettes in the presence of <t>GABAR</t> blockers at −60 mV in WT and Y647S +/− at increasing stimulus strengths. (E) AMPAR EPSC peak amplitude in WT and Y647S +/− at different stimuli is identical . (F) Paired pulse ratio at 20 ms interval is similar in WT and Y647S +/− neurons . (G) Isolated NMDAR EPSCs measured with AMPARs blocked at +40 mV in WT and Y647S +/− . (H) NMDAR EPSC peak amplitude is reduced in Y647S +/− neurons (∗ p < 0.05, ∗∗ p < 0.01, Sidak’s post hoc). (I) AMPA to NMDA ratio in WT and Y647S +/− neurons (∗ p < 0.05, unpaired t test). (Inset), EPSCs at −60 and +40 mV in WT and Y647S +/− , dotted line indicates NMDAR component at +40 mV. (J) Summary schematic showing preserved AMPAR but reduced NMDAR currents in Grin1 Y647S +/− mice. Bars denote mean ± SEM.
    Gamma Aminobutyric Acid Receptor Gabar Blockers, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gamma aminobutyric acid receptor gabar blockers/product/Alomone Labs
    Average 95 stars, based on 1 article reviews
    gamma aminobutyric acid receptor gabar blockers - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    94
    TargetMol γ-aminobutyric acid
    Isolated NMDARs show loss of function in mice with GluN1 Y647S +/− patient variant (A) Schematic showing the position of the Y647S mutation in the M3 transmembrane domain of the GluN1 NMDAR subunit (top), structure of the human GluN1-GluN2A NMDAR tetramer (PDB: 6IRF ) highlighting the Y647 site in the channel pore (bottom). (B) Tyrosine residue at the 647 th position of GluN1 is mutated to serine, causing severe seizures and intellectual disability in the patient. Mutant mice ( Grin1 Y647S +/− ) replicating the patient phenotype were used for slice electrophysiology. (C) Coronal prefrontal cortex slices from adult WT and mutant (Y647S +/− ) mice were used to record synaptic currents evoked by electrical stimulation of glutamate release in layer 5 pyramidal (L5 Pyr) neurons. (D) Schematic with position of stimulating and recording electrodes in the brain slice. Isolated AMPAR EPSCs measured using cesium gluconate patch pipettes in the presence of <t>GABAR</t> blockers at −60 mV in WT and Y647S +/− at increasing stimulus strengths. (E) AMPAR EPSC peak amplitude in WT and Y647S +/− at different stimuli is identical . (F) Paired pulse ratio at 20 ms interval is similar in WT and Y647S +/− neurons . (G) Isolated NMDAR EPSCs measured with AMPARs blocked at +40 mV in WT and Y647S +/− . (H) NMDAR EPSC peak amplitude is reduced in Y647S +/− neurons (∗ p < 0.05, ∗∗ p < 0.01, Sidak’s post hoc). (I) AMPA to NMDA ratio in WT and Y647S +/− neurons (∗ p < 0.05, unpaired t test). (Inset), EPSCs at −60 and +40 mV in WT and Y647S +/− , dotted line indicates NMDAR component at +40 mV. (J) Summary schematic showing preserved AMPAR but reduced NMDAR currents in Grin1 Y647S +/− mice. Bars denote mean ± SEM.
    γ Aminobutyric Acid, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/γ-aminobutyric acid/product/TargetMol
    Average 94 stars, based on 1 article reviews
    γ-aminobutyric acid - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    90
    Synaptic Systems anti-vesicular γ-aminobutyric acid transporter (vgat)
    Isolated NMDARs show loss of function in mice with GluN1 Y647S +/− patient variant (A) Schematic showing the position of the Y647S mutation in the M3 transmembrane domain of the GluN1 NMDAR subunit (top), structure of the human GluN1-GluN2A NMDAR tetramer (PDB: 6IRF ) highlighting the Y647 site in the channel pore (bottom). (B) Tyrosine residue at the 647 th position of GluN1 is mutated to serine, causing severe seizures and intellectual disability in the patient. Mutant mice ( Grin1 Y647S +/− ) replicating the patient phenotype were used for slice electrophysiology. (C) Coronal prefrontal cortex slices from adult WT and mutant (Y647S +/− ) mice were used to record synaptic currents evoked by electrical stimulation of glutamate release in layer 5 pyramidal (L5 Pyr) neurons. (D) Schematic with position of stimulating and recording electrodes in the brain slice. Isolated AMPAR EPSCs measured using cesium gluconate patch pipettes in the presence of <t>GABAR</t> blockers at −60 mV in WT and Y647S +/− at increasing stimulus strengths. (E) AMPAR EPSC peak amplitude in WT and Y647S +/− at different stimuli is identical . (F) Paired pulse ratio at 20 ms interval is similar in WT and Y647S +/− neurons . (G) Isolated NMDAR EPSCs measured with AMPARs blocked at +40 mV in WT and Y647S +/− . (H) NMDAR EPSC peak amplitude is reduced in Y647S +/− neurons (∗ p < 0.05, ∗∗ p < 0.01, Sidak’s post hoc). (I) AMPA to NMDA ratio in WT and Y647S +/− neurons (∗ p < 0.05, unpaired t test). (Inset), EPSCs at −60 and +40 mV in WT and Y647S +/− , dotted line indicates NMDAR component at +40 mV. (J) Summary schematic showing preserved AMPAR but reduced NMDAR currents in Grin1 Y647S +/− mice. Bars denote mean ± SEM.
    Anti Vesicular γ Aminobutyric Acid Transporter (Vgat), supplied by Synaptic Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-vesicular γ-aminobutyric acid transporter (vgat)/product/Synaptic Systems
    Average 90 stars, based on 1 article reviews
    anti-vesicular γ-aminobutyric acid transporter (vgat) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    93
    Krishgen Biosystems γ aminobutyric acid
    Isolated NMDARs show loss of function in mice with GluN1 Y647S +/− patient variant (A) Schematic showing the position of the Y647S mutation in the M3 transmembrane domain of the GluN1 NMDAR subunit (top), structure of the human GluN1-GluN2A NMDAR tetramer (PDB: 6IRF ) highlighting the Y647 site in the channel pore (bottom). (B) Tyrosine residue at the 647 th position of GluN1 is mutated to serine, causing severe seizures and intellectual disability in the patient. Mutant mice ( Grin1 Y647S +/− ) replicating the patient phenotype were used for slice electrophysiology. (C) Coronal prefrontal cortex slices from adult WT and mutant (Y647S +/− ) mice were used to record synaptic currents evoked by electrical stimulation of glutamate release in layer 5 pyramidal (L5 Pyr) neurons. (D) Schematic with position of stimulating and recording electrodes in the brain slice. Isolated AMPAR EPSCs measured using cesium gluconate patch pipettes in the presence of <t>GABAR</t> blockers at −60 mV in WT and Y647S +/− at increasing stimulus strengths. (E) AMPAR EPSC peak amplitude in WT and Y647S +/− at different stimuli is identical . (F) Paired pulse ratio at 20 ms interval is similar in WT and Y647S +/− neurons . (G) Isolated NMDAR EPSCs measured with AMPARs blocked at +40 mV in WT and Y647S +/− . (H) NMDAR EPSC peak amplitude is reduced in Y647S +/− neurons (∗ p < 0.05, ∗∗ p < 0.01, Sidak’s post hoc). (I) AMPA to NMDA ratio in WT and Y647S +/− neurons (∗ p < 0.05, unpaired t test). (Inset), EPSCs at −60 and +40 mV in WT and Y647S +/− , dotted line indicates NMDAR component at +40 mV. (J) Summary schematic showing preserved AMPAR but reduced NMDAR currents in Grin1 Y647S +/− mice. Bars denote mean ± SEM.
    γ Aminobutyric Acid, supplied by Krishgen Biosystems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/γ aminobutyric acid/product/Krishgen Biosystems
    Average 93 stars, based on 1 article reviews
    γ aminobutyric acid - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Proteintech rabbit anti vesicular gamma aminobutyric acid gaba transporter vgat antibody
    Isolated NMDARs show loss of function in mice with GluN1 Y647S +/− patient variant (A) Schematic showing the position of the Y647S mutation in the M3 transmembrane domain of the GluN1 NMDAR subunit (top), structure of the human GluN1-GluN2A NMDAR tetramer (PDB: 6IRF ) highlighting the Y647 site in the channel pore (bottom). (B) Tyrosine residue at the 647 th position of GluN1 is mutated to serine, causing severe seizures and intellectual disability in the patient. Mutant mice ( Grin1 Y647S +/− ) replicating the patient phenotype were used for slice electrophysiology. (C) Coronal prefrontal cortex slices from adult WT and mutant (Y647S +/− ) mice were used to record synaptic currents evoked by electrical stimulation of glutamate release in layer 5 pyramidal (L5 Pyr) neurons. (D) Schematic with position of stimulating and recording electrodes in the brain slice. Isolated AMPAR EPSCs measured using cesium gluconate patch pipettes in the presence of <t>GABAR</t> blockers at −60 mV in WT and Y647S +/− at increasing stimulus strengths. (E) AMPAR EPSC peak amplitude in WT and Y647S +/− at different stimuli is identical . (F) Paired pulse ratio at 20 ms interval is similar in WT and Y647S +/− neurons . (G) Isolated NMDAR EPSCs measured with AMPARs blocked at +40 mV in WT and Y647S +/− . (H) NMDAR EPSC peak amplitude is reduced in Y647S +/− neurons (∗ p < 0.05, ∗∗ p < 0.01, Sidak’s post hoc). (I) AMPA to NMDA ratio in WT and Y647S +/− neurons (∗ p < 0.05, unpaired t test). (Inset), EPSCs at −60 and +40 mV in WT and Y647S +/− , dotted line indicates NMDAR component at +40 mV. (J) Summary schematic showing preserved AMPAR but reduced NMDAR currents in Grin1 Y647S +/− mice. Bars denote mean ± SEM.
    Rabbit Anti Vesicular Gamma Aminobutyric Acid Gaba Transporter Vgat Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti vesicular gamma aminobutyric acid gaba transporter vgat antibody/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit anti vesicular gamma aminobutyric acid gaba transporter vgat antibody - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    94
    MedChemExpress γ aminobutyric acid
    Isolated NMDARs show loss of function in mice with GluN1 Y647S +/− patient variant (A) Schematic showing the position of the Y647S mutation in the M3 transmembrane domain of the GluN1 NMDAR subunit (top), structure of the human GluN1-GluN2A NMDAR tetramer (PDB: 6IRF ) highlighting the Y647 site in the channel pore (bottom). (B) Tyrosine residue at the 647 th position of GluN1 is mutated to serine, causing severe seizures and intellectual disability in the patient. Mutant mice ( Grin1 Y647S +/− ) replicating the patient phenotype were used for slice electrophysiology. (C) Coronal prefrontal cortex slices from adult WT and mutant (Y647S +/− ) mice were used to record synaptic currents evoked by electrical stimulation of glutamate release in layer 5 pyramidal (L5 Pyr) neurons. (D) Schematic with position of stimulating and recording electrodes in the brain slice. Isolated AMPAR EPSCs measured using cesium gluconate patch pipettes in the presence of <t>GABAR</t> blockers at −60 mV in WT and Y647S +/− at increasing stimulus strengths. (E) AMPAR EPSC peak amplitude in WT and Y647S +/− at different stimuli is identical . (F) Paired pulse ratio at 20 ms interval is similar in WT and Y647S +/− neurons . (G) Isolated NMDAR EPSCs measured with AMPARs blocked at +40 mV in WT and Y647S +/− . (H) NMDAR EPSC peak amplitude is reduced in Y647S +/− neurons (∗ p < 0.05, ∗∗ p < 0.01, Sidak’s post hoc). (I) AMPA to NMDA ratio in WT and Y647S +/− neurons (∗ p < 0.05, unpaired t test). (Inset), EPSCs at −60 and +40 mV in WT and Y647S +/− , dotted line indicates NMDAR component at +40 mV. (J) Summary schematic showing preserved AMPAR but reduced NMDAR currents in Grin1 Y647S +/− mice. Bars denote mean ± SEM.
    γ Aminobutyric Acid, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/γ aminobutyric acid/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    γ aminobutyric acid - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    93
    Proteintech γ aminobutyric acid type a receptor subunit α1 gabra1
    Isolated NMDARs show loss of function in mice with GluN1 Y647S +/− patient variant (A) Schematic showing the position of the Y647S mutation in the M3 transmembrane domain of the GluN1 NMDAR subunit (top), structure of the human GluN1-GluN2A NMDAR tetramer (PDB: 6IRF ) highlighting the Y647 site in the channel pore (bottom). (B) Tyrosine residue at the 647 th position of GluN1 is mutated to serine, causing severe seizures and intellectual disability in the patient. Mutant mice ( Grin1 Y647S +/− ) replicating the patient phenotype were used for slice electrophysiology. (C) Coronal prefrontal cortex slices from adult WT and mutant (Y647S +/− ) mice were used to record synaptic currents evoked by electrical stimulation of glutamate release in layer 5 pyramidal (L5 Pyr) neurons. (D) Schematic with position of stimulating and recording electrodes in the brain slice. Isolated AMPAR EPSCs measured using cesium gluconate patch pipettes in the presence of <t>GABAR</t> blockers at −60 mV in WT and Y647S +/− at increasing stimulus strengths. (E) AMPAR EPSC peak amplitude in WT and Y647S +/− at different stimuli is identical . (F) Paired pulse ratio at 20 ms interval is similar in WT and Y647S +/− neurons . (G) Isolated NMDAR EPSCs measured with AMPARs blocked at +40 mV in WT and Y647S +/− . (H) NMDAR EPSC peak amplitude is reduced in Y647S +/− neurons (∗ p < 0.05, ∗∗ p < 0.01, Sidak’s post hoc). (I) AMPA to NMDA ratio in WT and Y647S +/− neurons (∗ p < 0.05, unpaired t test). (Inset), EPSCs at −60 and +40 mV in WT and Y647S +/− , dotted line indicates NMDAR component at +40 mV. (J) Summary schematic showing preserved AMPAR but reduced NMDAR currents in Grin1 Y647S +/− mice. Bars denote mean ± SEM.
    γ Aminobutyric Acid Type A Receptor Subunit α1 Gabra1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/γ aminobutyric acid type a receptor subunit α1 gabra1/product/Proteintech
    Average 93 stars, based on 1 article reviews
    γ aminobutyric acid type a receptor subunit α1 gabra1 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    94
    MedChemExpress gaba
    Isolated NMDARs show loss of function in mice with GluN1 Y647S +/− patient variant (A) Schematic showing the position of the Y647S mutation in the M3 transmembrane domain of the GluN1 NMDAR subunit (top), structure of the human GluN1-GluN2A NMDAR tetramer (PDB: 6IRF ) highlighting the Y647 site in the channel pore (bottom). (B) Tyrosine residue at the 647 th position of GluN1 is mutated to serine, causing severe seizures and intellectual disability in the patient. Mutant mice ( Grin1 Y647S +/− ) replicating the patient phenotype were used for slice electrophysiology. (C) Coronal prefrontal cortex slices from adult WT and mutant (Y647S +/− ) mice were used to record synaptic currents evoked by electrical stimulation of glutamate release in layer 5 pyramidal (L5 Pyr) neurons. (D) Schematic with position of stimulating and recording electrodes in the brain slice. Isolated AMPAR EPSCs measured using cesium gluconate patch pipettes in the presence of <t>GABAR</t> blockers at −60 mV in WT and Y647S +/− at increasing stimulus strengths. (E) AMPAR EPSC peak amplitude in WT and Y647S +/− at different stimuli is identical . (F) Paired pulse ratio at 20 ms interval is similar in WT and Y647S +/− neurons . (G) Isolated NMDAR EPSCs measured with AMPARs blocked at +40 mV in WT and Y647S +/− . (H) NMDAR EPSC peak amplitude is reduced in Y647S +/− neurons (∗ p < 0.05, ∗∗ p < 0.01, Sidak’s post hoc). (I) AMPA to NMDA ratio in WT and Y647S +/− neurons (∗ p < 0.05, unpaired t test). (Inset), EPSCs at −60 and +40 mV in WT and Y647S +/− , dotted line indicates NMDAR component at +40 mV. (J) Summary schematic showing preserved AMPAR but reduced NMDAR currents in Grin1 Y647S +/− mice. Bars denote mean ± SEM.
    Gaba, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gaba/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    gaba - by Bioz Stars, 2026-03
    94/100 stars
      Buy from Supplier

    Image Search Results


    Isolated NMDARs show loss of function in mice with GluN1 Y647S +/− patient variant (A) Schematic showing the position of the Y647S mutation in the M3 transmembrane domain of the GluN1 NMDAR subunit (top), structure of the human GluN1-GluN2A NMDAR tetramer (PDB: 6IRF ) highlighting the Y647 site in the channel pore (bottom). (B) Tyrosine residue at the 647 th position of GluN1 is mutated to serine, causing severe seizures and intellectual disability in the patient. Mutant mice ( Grin1 Y647S +/− ) replicating the patient phenotype were used for slice electrophysiology. (C) Coronal prefrontal cortex slices from adult WT and mutant (Y647S +/− ) mice were used to record synaptic currents evoked by electrical stimulation of glutamate release in layer 5 pyramidal (L5 Pyr) neurons. (D) Schematic with position of stimulating and recording electrodes in the brain slice. Isolated AMPAR EPSCs measured using cesium gluconate patch pipettes in the presence of GABAR blockers at −60 mV in WT and Y647S +/− at increasing stimulus strengths. (E) AMPAR EPSC peak amplitude in WT and Y647S +/− at different stimuli is identical . (F) Paired pulse ratio at 20 ms interval is similar in WT and Y647S +/− neurons . (G) Isolated NMDAR EPSCs measured with AMPARs blocked at +40 mV in WT and Y647S +/− . (H) NMDAR EPSC peak amplitude is reduced in Y647S +/− neurons (∗ p < 0.05, ∗∗ p < 0.01, Sidak’s post hoc). (I) AMPA to NMDA ratio in WT and Y647S +/− neurons (∗ p < 0.05, unpaired t test). (Inset), EPSCs at −60 and +40 mV in WT and Y647S +/− , dotted line indicates NMDAR component at +40 mV. (J) Summary schematic showing preserved AMPAR but reduced NMDAR currents in Grin1 Y647S +/− mice. Bars denote mean ± SEM.

    Journal: iScience

    Article Title: Context-dependent NMDA receptor dysfunction predicts seizure treatment in mice with human GluN1 variant

    doi: 10.1016/j.isci.2025.114301

    Figure Lengend Snippet: Isolated NMDARs show loss of function in mice with GluN1 Y647S +/− patient variant (A) Schematic showing the position of the Y647S mutation in the M3 transmembrane domain of the GluN1 NMDAR subunit (top), structure of the human GluN1-GluN2A NMDAR tetramer (PDB: 6IRF ) highlighting the Y647 site in the channel pore (bottom). (B) Tyrosine residue at the 647 th position of GluN1 is mutated to serine, causing severe seizures and intellectual disability in the patient. Mutant mice ( Grin1 Y647S +/− ) replicating the patient phenotype were used for slice electrophysiology. (C) Coronal prefrontal cortex slices from adult WT and mutant (Y647S +/− ) mice were used to record synaptic currents evoked by electrical stimulation of glutamate release in layer 5 pyramidal (L5 Pyr) neurons. (D) Schematic with position of stimulating and recording electrodes in the brain slice. Isolated AMPAR EPSCs measured using cesium gluconate patch pipettes in the presence of GABAR blockers at −60 mV in WT and Y647S +/− at increasing stimulus strengths. (E) AMPAR EPSC peak amplitude in WT and Y647S +/− at different stimuli is identical . (F) Paired pulse ratio at 20 ms interval is similar in WT and Y647S +/− neurons . (G) Isolated NMDAR EPSCs measured with AMPARs blocked at +40 mV in WT and Y647S +/− . (H) NMDAR EPSC peak amplitude is reduced in Y647S +/− neurons (∗ p < 0.05, ∗∗ p < 0.01, Sidak’s post hoc). (I) AMPA to NMDA ratio in WT and Y647S +/− neurons (∗ p < 0.05, unpaired t test). (Inset), EPSCs at −60 and +40 mV in WT and Y647S +/− , dotted line indicates NMDAR component at +40 mV. (J) Summary schematic showing preserved AMPAR but reduced NMDAR currents in Grin1 Y647S +/− mice. Bars denote mean ± SEM.

    Article Snippet: Gamma-aminobutyric acid receptor (GABAR) blockers (Picrotoxin 20 μM, Alomone Labs , CGP52432 1 μM, Tocris ) were included in all recordings, and AMPAR blocker (CNQX or NBQX 20 μM, Alomone Labs ) was used to isolate synaptic NMDAR currents at +40 mV.

    Techniques: Isolation, Variant Assay, Mutagenesis, Residue, Slice Preparation

    Paradoxically prolonged NMDAR integration in Grin1 Y647S +/− mice (A) Schematic showing that a single stimulus evokes limited glutamate release that activates only synaptic receptors, while repetitive high frequency stimulation causes glutamate spillover onto the dendrite, generating a dendritic plateau potential. (B) Average NMDAR plateau potentials in WT and Y647S +/− neurons evoked by 50 Hz stimulation, measured in the presence of AMPAR and GABAR blockers. (Inset) Plateau potential amplitude (normalized to the spike threshold) at different stimulus intensities in WT and Y647S +/− (∗ p < 0.05, Sidak’s post hoc). (C) NMDAR plateau potentials show extended duration in Y647S +/− neurons compared to WT at multiple stimulus intensities. (D) Area under the plateau potential for the 1 s period post-stimulation (late area) at different stimuli in WT and Y647S +/− (∗∗∗∗ p < 10 −4 , Sidak’s post hoc). (E) Total duration of the plateau potential (at 50 μA stimulation) in WT and Y647S +/− neurons (∗ p < 0.05, unpaired t test).

    Journal: iScience

    Article Title: Context-dependent NMDA receptor dysfunction predicts seizure treatment in mice with human GluN1 variant

    doi: 10.1016/j.isci.2025.114301

    Figure Lengend Snippet: Paradoxically prolonged NMDAR integration in Grin1 Y647S +/− mice (A) Schematic showing that a single stimulus evokes limited glutamate release that activates only synaptic receptors, while repetitive high frequency stimulation causes glutamate spillover onto the dendrite, generating a dendritic plateau potential. (B) Average NMDAR plateau potentials in WT and Y647S +/− neurons evoked by 50 Hz stimulation, measured in the presence of AMPAR and GABAR blockers. (Inset) Plateau potential amplitude (normalized to the spike threshold) at different stimulus intensities in WT and Y647S +/− (∗ p < 0.05, Sidak’s post hoc). (C) NMDAR plateau potentials show extended duration in Y647S +/− neurons compared to WT at multiple stimulus intensities. (D) Area under the plateau potential for the 1 s period post-stimulation (late area) at different stimuli in WT and Y647S +/− (∗∗∗∗ p < 10 −4 , Sidak’s post hoc). (E) Total duration of the plateau potential (at 50 μA stimulation) in WT and Y647S +/− neurons (∗ p < 0.05, unpaired t test).

    Article Snippet: Gamma-aminobutyric acid receptor (GABAR) blockers (Picrotoxin 20 μM, Alomone Labs , CGP52432 1 μM, Tocris ) were included in all recordings, and AMPAR blocker (CNQX or NBQX 20 μM, Alomone Labs ) was used to isolate synaptic NMDAR currents at +40 mV.

    Techniques: